The Snowdome Foundation has partnered with Cure Cancer and Cancer Australia to fund a new novel myeloma research project. The research will investigate a new diagnostic marker for treatment resistant myeloma. The team will investigate if treatment targeting this marker will improve response in those who do not respond… Read More
Dr Josh Tobin is the recipient of our first Snowdome Haematology Fellowship. His research project is looking at new diagnostic techniques to uncover follicular lymphoma patients that have aggressive cancer which is likely to return quickly after chemotherapy treatment. “Ultimately, his project addresses the unmet need to better identify high-risk follicular… Read More
Prof. Ravindra Majeti (Stanford University) and Assoc. Prof. Dan Thomas (South Australia Health Medical Research Institute) Prof. Majeti and Assoc. Prof. Thomas recently discovered a strong link between the metabolism of leukemia cells and common leukemia-causing mutations through modulation of a central metabolic factor called alpha ketoglutarate. They have since… Read More
Dr Katherine Cummins is the recipient of our female fellowship specifically directed at Haematology career development in medical research. The Snowdome Foundation and Maddie Riewoldt’s Vision are passionate about supporting the advancement of women in medical research and are funding this fellowship together with the support of the Gunn Family. Read More
Blood Cancer Research WA has been established to ensure patients in WA have access to new blood cancer treatments through clinical trials without having to travel interstate. Patients on clinical trials are shown to have improved outcomes. Help WA blood cancer patients by funding an increase in human infrastructure (Fellows,… Read More
Dr Kylee Maclachlan has been awarded a three-year fellowship in myeloma to Memorial Sloan Kettering Cancer Centre in New York City. Funding is required to assist Dr Maclachlan as she collaborates on an International trial that will bring novel therapies for the treatment of myeloma to Australia. The trial will… Read More
Paediatric Dr. Charles Mullighan (St. Jude Children’s Research Hospital) Acute lymphoblastic leukemia (ALL) remains a leading cause of childhood cancer death, and one type of this disease, Philadelphia-like ALL (Ph-like ALL), has an extremely poor outcome. A common feature of Ph-like ALL is the aberrant function of a particular… Read More
